EGFR and non-small cell lung carcinoma: Reports have shown that this treatment strategy for EGFR+ NSCLC patients with LM has produced various results.15, 16 Kuiper et al. reported that 12 EGFR+ NSCLC patients with LM treated with high dose first‐generation EGFR‐TKIs after LM diagnosis achieved survival after LM of only 2.4 months.4